A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants
Phase 1
Recruiting
- Conditions
- ot applicable - Healthy volonteersMedDRA version: 20.0Level: LLTClassification code: 10014697Term: Endocrine disorder NOS Class: 10014698Therapeutic area: Diseases [C] - Hormonal diseases [C19]
- Registration Number
- CTIS2024-512578-83-00
- Lead Sponsor
- Structure Therapeutics Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method